Next Article in Journal
Comparative Analysis of Multi-Organ Failure Trajectories Following Heart Transplantation and HeartMate 3 Implantation: A 1-Year Postprocedural Follow-Up Study Utilizing the MELD-XI Scale
Previous Article in Journal
Serum Levels of HMGB1, hS100A8/A9, and sRAGE in Patients with Knee and Hip Osteoarthritis: Inflammatory Biomarkers of Disease Activity
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Reconstruction After Wide Excision of the Nail Apparatus in the Treatment of Melanoma: A Systematic Literature Review

1
Plastic Surgery Department, Institut Universitaire Locomoteur et du Sport, Pasteur 2 Hospital, University Côte d’Azur, 06100 Nice, France
2
Dermatology Department, L’Archet Hospital, University Côte d’Azur, 06100 Nice, France
3
Laboratory of Molecular PhysioMedicine (LP2M), CNRS, University Côte d’Azur, 06100 Nice, France
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2025, 14(17), 5932; https://doi.org/10.3390/jcm14175932
Submission received: 22 July 2025 / Revised: 12 August 2025 / Accepted: 19 August 2025 / Published: 22 August 2025

Abstract

Background/Objectives: Historically, the treatment of subungual melanoma was based on amputation of the affected digit. However, extended wide local excision of the nail apparatus is now considered the conservative gold standard for in situ or minimally invasive forms. There are many after wide local excision reconstruction techniques, but few studies have objectively compared their results. The objectives were to carry out a systematic review of reconstruction after wide local excision reconstructions in the treatment of subungual melanoma. Methods: This systematic review was conducted following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. An exhaustive search was conducted in the PubMed (Medline), Embase, and Cochrane Library databases, up to July 2025. Articles reporting reconstructions after wide local excision for subungual melanoma of the fingers or toes were included. Clinical, technical, and outcome data were analyzed. Results: The literature review comprised 24 articles on 373 patients, primarily those with in situ subungual melanoma. Reconstruction was most often performed using total skin grafts, sometimes combined with dermal matrices. Some authors used local or free flaps. Few studies used validated functional scores. Local recurrences were significant, affecting 18% of patients and requiring secondary amputation. Conclusions: Nail apparatus reconstructions are primarily indicated for in situ or minimally invasive subungual melanomas. Immediate reconstruction carries a risk of performing the reconstruction over residual tumor tissue, particularly in the case of invasive melanomas. Reconstructive techniques, such as full-thickness skin grafts and the use of dermal matrices, can provide satisfactory functional and aesthetic outcomes. However, objective evaluations of these results remain limited, and better standardization of clinical practice, along with prospective studies, is needed to refine long-term outcome assessment.

1. Introduction

Melanoma is a significant public health concern, with over 330,000 new cases and more than 58,000 deaths per year worldwide by 2022 [1]. One of the major prognostic factors for cutaneous melanoma is the Breslow index, which corresponds to the measured vertical thickness of the tumor, expressed in millimeters, from the top of the granular layer of the epidermis (or the base of an ulcer, if present) to the deepest point of tumor invasion in the dermis or subcutis. A greater Breslow thickness is strongly associated with a higher risk of recurrence and poorer survival outcomes [2,3]. However, subsequent genomic studies have suggested that this paradigm may not fully apply to nail apparatus melanoma, which appears genetically distinct from acral and other cutaneous melanomas, potentially influencing prognostic interpretation [4]. Subungual melanomas (SUM) belong to the subcategory of acral-lentiginous melanomas, which represent approximately 0.7 to 3.5% of all melanomas in Caucasians but can be as high as 50% in Asian or African Caribbean subjects [5,6]. SUM is most frequently found in the nail matrix, where it manifests as a dark, heterochromatic, longitudinal melanonychia with ill-defined contours that can sometimes invade adjacent skin folds. Historically, treatment was based on systematic amputation of the affected digit, often resulting in significant functional loss and cosmetic damage, which had a considerable impact on quality of life [7]. Today, it has been established that in situ or minimally invasive melanomas can be treated conservatively, by wide local excision (WLE) of the nail apparatus [8,9,10]. SUM involves excision of the entire nail with margins generally between 5 and 10 mm, and immediate or delayed reconstruction [11]. The choice of reconstruction technique is complex and not consensual, particularly when the excision is large, local functional requirements are essential, and scarring threatens to cause cosmetic damage with social repercussions [12,13].
To better identify the possibility of reconstruction, we conducted a systematic review of the literature on surgical techniques used in nail reconstruction following SUM.
The objective of this review was to systematically evaluate the oncologic, functional, and aesthetic outcomes of conservative versus amputation surgical techniques for subungual melanoma, focusing on recurrence rates, reconstruction methods, and long-term quality-of-life impact.

2. Materials and Methods

  • Literature search
This systematic review was conducted following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines [14]. An exhaustive search was conducted in PubMed/MEDLINE, Embase, Scopus, and Web of Science from their creation to July 2025. The keywords used were (‘Nail apparatus Melanoma’ OR ‘Nail Matrix Melanoma’ OR ‘Subungual Melanoma’) AND (‘reconstruction’ OR “flap” OR ‘dermal matrix’ OR ‘skin graft’ OR ‘healing’). Searches in Scopus and Web of Science did not identify additional eligible articles beyond those retrieved from PubMed and Embase. A manual search for the bibliographies of relevant articles completed the analysis. Only articles in English, Spanish, and French were retained. After an initial screening of titles and abstracts, duplicates, irrelevant studies, literature reviews, animal studies, and cases of amputation were excluded. The full texts were then analyzed, and purely anatomical studies were excluded. The institutional ethics committee has approved this research project.
  • Study Selection
Studies were included according to the following criteria:
-
Type of study: case series, case reports, cohort studies, and randomized controlled trials of nail reconstruction after melanoma removal.
-
Participants: adult or pediatric patients undergoing reconstruction after removal of a subungual melanoma of the upper or lower limb.
-
Results reported: type of melanoma and excision (margins), reconstruction technique, time frame, adjuvant treatments, complications, functional and aesthetic results, patient satisfaction, recurrences, and length of follow-up.
Two reviewers (L.C. and E.L.) independently examined the titles and abstracts and then the full texts of potentially eligible articles. Disagreements were resolved by discussion or arbitration by a third reviewer (O.C.).
  • Data Collection
Due to the heterogeneity of the studies (in terms of design, population, and techniques), a meta-analysis was not feasible. A narrative summary was produced, and the results were presented in the form of summary tables, which brought together the main characteristics and conclusions of the included studies. Data were independently extracted by two reviewers using a standardized data collection form. Extracted variables included study design, population characteristics, surgical technique, follow-up duration, recurrence, functional and aesthetic outcomes, and complications.
  • Data synthesis and analysis
Given the heterogeneity of study designs and outcome measures, a meta-analysis was not preferred. Instead, a narrative synthesis of the included studies was carried out. The data were organized and summarized in tabular form, highlighting the characteristics of the included studies, key findings, and outcomes of interest. In addition to extracting clinical and technical variables, we assessed the methodological quality of each included study. Risk of bias was evaluated independently by two reviewers using the Newcastle–Ottawa Scale (NOS) for observational studies and the Joanna Briggs Institute (JBI) checklists for case series or single case reports; disagreements were resolved by consensus. For each study, we also recorded the method used to assess functional and/or aesthetic outcomes, specifying whether validated patient-reported outcome measures (PROMs) were employed.

3. Results

  • Study selection
The study selection process is summarized in the PRISMA 2020 flow diagram (Figure 1). An initial search conducted in the PubMed and TRIP databases identified 593 articles. After removing duplicates and excluding articles written in languages other than French, English, or Spanish, 547 unique references were included for screening. Title and abstract review led to the selection of 45 articles for full-text assessment. Of these, 21 were excluded: 16 focused on cases managed by amputation, 1 provided insufficient data, and 4 dealt with acral lentiginous melanomas at unrelated anatomical sites. In total, 24 studies met the predefined inclusion and exclusion criteria and were included in the analysis (Figure 1).
  • Study characteristics
Of the 24 studies selected, 18 were case series [15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32], and 6 were single case reports [33,34,35,36,37,38]. All the studies were retrospective (n = 23), except for one study, which was a prospective case series [38]. All the studies were published between 2003, for the oldest [19], and 2023, for the most recent [22]. Table 1 summarizes the characteristics of the included studies.
Quality assessment revealed an overall moderate methodological level across the included studies. Most clearly stated their inclusion criteria and surgical protocols, but sample sizes were generally small, and comparative designs were rare. According to the Newcastle–Ottawa Scale (NOS) and Joanna Briggs Institute (JBI) checklist, depending on study design, methodological quality was rated as moderate in 13 studies, moderate-to-high in 8, and high in 3. Only one study [24] employed psychometrically validated patient-reported outcome measures (QuickDASH and Foot Function Index); all others relied on non-validated Likert-type or clinical scales for functional and aesthetic evaluation. Outcome assessment was heterogeneous, most often based on qualitative surgeon or patient appraisal (e.g., overall satisfaction, pain reports, or return to daily activities). Full details of the quality appraisal, including individual study ratings and notes on outcomes, are available in Supplementary Table S1.
  • Demographic characteristics
Sample sizes varied from study to study, ranging from 1 to 140 [22] participants, for a total of 373 patients, with an average age of 53.4 years (4 to 81 years). Women predominated, comprising 252 of the 373 patients, which represents a sex ratio of 67%.
One study did not specify the sex of the patients [28].
  • Anatomical localization
Of the articles included for which the location was specified, 91 patients had involvement of the lower limb, including 25 cases involving the hallux when this information was available, and 164 patients had involvement of the upper limb, including 50 cases involving the thumb. However, for 118 patients, the precise anatomical location was not reported. Four studies did not mention the location of the lesion at all [17,19,24,27].
  • Melanoma type
Regarding the diagnostic phase, the majority of articles [18,22,24,25,26,28,30,32,33,35,36,37] reported that an initial biopsy was performed. Only one article [34] mentioned an immediate biopsy-exeresis, while two studies [20,38] noted the absence of a biopsy. The presence or absence of prior biopsy was not specified in nine articles [15,16,17,19,21,23,27,29,31]. When the degree of local invasion was reported, the majority of melanomas were in situ (n = 65). Among the invasive forms, five cases had a Breslow index of less than 1 mm, two cases had a Breslow index between 1 and 3 mm, and two cases had a Breslow index of more than 3 mm. Six studies did not mention the stage of the melanoma [19,20,22,23,24].
  • Margins
These margins were not tumor resection margins in the strict sense of the term, but margins for resection of the entire nail apparatus, generally set at 5 mm in the majority of studies [15,16,17,18,19,20,21,24,26,36,37,38]. However, some publications have reported wider margins of 10 mm [25,33,35,37], while others have recommended narrower margins of 3 mm [22,34]. The standard Mohs micrographic surgery technique was used in two studies [27,32], and the delayed Mohs or ‘Slow Mohs’ technique was also mentioned in two other publications [27,32]. Finally, one study reported the use of extemporaneous anatomopathological examination to check the margins of excision of the nail apparatus [30].
  • Strategy for reconstruction
Full-thickness skin graft (FTSG) was the preferred reconstruction technique in the majority of studies [15,16,17,18,19,20,21,23,25,26,29,32,33,34], involving a total of 112 patients. Of these, ten studies [16,17,18,21,25,26,29,32,33,34] reported that FTSG was performed immediately, at the same time as the extended excision, in 52 patients. In contrast, seven studies reported delayed reconstruction, involving 55 patients [16,17,19,20,26,30,31,32,34,35,38]. The immediate or delayed nature of the reconstruction was not specified in four publications [15,20,23,27].
Only the series by Crisan et al. reported the use of a negative pressure dressing in preparation for delayed FTSG [31]. FTSG was used exclusively in 71 patients [15,16,17,20,21,23,25,26,31,32,33,34], combined with a dermal matrix in 5 cases [30,35,38], and combined with a perionychium flap in 43 patients [18,19,21]. One study used a delayed thin skin graft after Mohs micrographic analysis [27].
Concerning the use of dermal matrices, three articles [30,35,38] were concerned, involving a total of five patients, for whom the dermal matrix was placed at the same time as the resection, and a second stage with the placement of an FTSG three weeks after the first stage was carried out. Only the PELNAC® matrix was used, except in one study where INTEGRA® was used [35].
With regard to flaps, only Motta et al. and Lee et al. [24,37] utilized free flaps, respectively, a free toe transfer in 1 case, and ultra-thin superficial circumflex iliac artery perforator flaps (SCIP) in 41 cases. In contrast, eight studies mentioned local flaps, six of which were associated with an FTSG [15,18,19,20,21,32] and two used exclusive Foucher flap reconstruction [28,36]. Local flaps combined with FTSG were most often perionychium advancement or palmar advancement flaps [18,19,21]; one case report proposed a cross-finger flap [32]. Finally, two studies favored directed healing only [20,27], and one study did not mention the surgical technique for reconstruction [37].
  • Carcinologic complications
The most frequently observed complication was melanoma recurrence, which was reported in 11 studies [17,19,20,21,22,23,24,26,27,28,31,32] involving a total of 67 patients. Of these, 13 required secondary amputation of the affected digit [17,20,21,26,27,28,31,32]. In two cases, recurrence was linked to histologically positive excision margins, requiring amputation [17,31].
In a further 33 cases, the status of the margins was not specified, and the treatment options varied: 11 patients underwent amputation [20,21,26,27,28,32], and 5 underwent revision surgery of the margins [19,24,27], including 3 by deferred Mohs technique [27].
Early recurrences, occurring within the first year after surgery, were reported in 15 patients [17,19,20]. There were two cases of SUM in situ and one invasive SUM with a thickness of 2.5 mm when specified [19,22,30]. The margins used in these studies were 3 mm in the series by Oh et al. [22], 5 mm in two series [17,19], and between 5 and 10 mm in one series [22]. The mean time from diagnosis to occurrence was 8 months after surgery.
Late recurrences, defined as occurring at least one year after surgery, were the most frequent, with 28 patients reported [18,20,21,22,24,25,30]. These included SUM in situ in five cases [24,25], invasive stage T1 in one case [25], stage T2 in two cases [22,25], stage T3 in two cases [25], and stage T4 in two cases [21,25], as specified. Among these articles, the margins used around the nail apparatus were 3 mm [20], 5 mm [18], 6 mm [24,25], and 5 to 10 mm [22]. These recurrences were found at the surgical site in 36 cases [18,20,24,25], in transit in 1 case [22], and reached the lymph node area concerned in 1 case [21]. The average time to recurrence was 29 months after surgery.
As regards distant localization recurrence, 21 cases were described [19,21,22,23,24,27], including the following:
Two transit metastases, one of which was treated surgically [19,24];
Ten lymph node involvement [19,23];
Eleven visceral metastases, resulting in 2 deaths [19,21,22,27].
These recurrences occurred on average 20 months after the first operation. They complicated a grade T3 melanoma in five cases [1,25] and a grade T4 in one case [19]. The nail margins found in these cases measured 5 mm in three series, involving 18 patients [17,19,25].
  • Non-carcinologic post-operative complications
    Residual nail spicules were reported in 15 patients [15,17,18,20], and epidermal cysts were found in 13 patients [15,16,17,20]. Other adverse events included the following:
    Ten cases of hypersensitivity to cold or shock;
    Nine cases of graft hyperpigmentation [15];
    One case of distal interphalangeal arthritis [31];
    One flexor sheath hematoma [26];
    One case of temporary functional exclusion of the finger [16].
Six studies reported no complications [25,29,30,35,36,38], and two did not mention this criterion [33,37]
  • Complementary treatments
Most studies did not mention complementary treatments (n = 23).
Only one study (31) described complementary treatments, with an adjuvant course of Interferon alpha for one patient, in the context of the appearance of distant metastases. This same study also described a case of recurrence treated by radiotherapy, with an unspecified impact on the outcome of reconstruction, and a case of multiple recurrences of metastases in transit treated by iterative excision and directed healing. The sentinel node procedure was mentioned only in the study by Wollina et al., involving four patients, only one of whom had a micrometastasis [23]. No study mentioned immunotherapy.
  • Functional and cosmetic results
Post-operative functional and cosmetic results were assessed by the examiner in six studies [20,31,33,34,35,37], by the patient in six other studies [16,17,18,24,30,36], and by the patient and the examiner in one study [25]; six studies did not mention who the assessor was [15,19,26,27,29,35,38].
Functional recovery was judged acceptable to satisfactory in eight studies, involving a total of 80 patients [15,16,18,19,20,25,30,31], whereas it was considered total, with a return to normal function, in seven studies [16,20,26,34,35,36,37] involving 39 patients.
Regarding the cosmetic result, it was judged to be little disturbed or good in 12 articles [15,17,18,19,20,25,28,30,31,33,35,38], involving 76 patients. In contrast, it was judged to be excellent or equivalent to the previous state in four studies [20,26,36,37], involving 42 patients with heterogeneous surgical techniques: exclusive directed healing [20], Foucher flap in the case report of one patient [36], free onycho-cutaneous flap harvested from the hallux in the case report of one patient [37], and six cases treated by FTSG and five by exclusive directed healing in the series by Neczyporenko et al. [26]. The cosmetic result was judged to be poor in only two patients in the series by Goettmann et al. [20], but although directed healing was the predominant choice, the technique used for these two patients was not specified.
Only one article classified its results using validated questionnaires, that of Lee et al. [24], which found an average Quick-Disabilities of the Arm, Shoulder and Hand (DASH) score of 1.3 in the 14 patients undergoing surgery on the upper limb and an average Foot Function Index (FFI) score of 3.1 in the 12 patients undergoing surgery on the lower limb.
The time to return to work was specified in two studies [31,35], and averaged four and six weeks, respectively, after the last operation.
  • Post-operative follow-up
Reported follow-up ranged from 3 months [36,37,38] to 120 months [20].
The mean follow-up was 60.1 months, with a mean of 45 months.

4. Discussion

The management of subungual melanoma has evolved significantly since its first description in the nineteenth century [39]. This topographical form appears to affect women preferentially, as indicated by our review (women authored 67% of the 24 articles included), in line with the data of Neczyporenko et al. [26].
Regarding the age of onset, the fifth decade is the most frequently reported, with a few exceptions, such as the series by Lazar et al. [16], where the mean age was 40. Preoperative biopsy is not usually recommended for pigmented skin lesions in favor of excisional biopsy [40]. However, in certain functional or aesthetically sensitive areas, a biopsy may be justified as a first-line procedure. In our review, several studies did not specify the performance of a biopsy and its modality, or mentioned the absence of one, which exposes the risk of unnecessary mutilating surgery, even in the presence of effective reconstruction techniques. EAU is now preferred to amputation in cases of in situ or minimally invasive melanoma, although there is no agreed Breslow threshold [41,42]. Most articles support this strategy, with a recurrence rate comparable to that of amputation [16,19,28,43,44].
Although some studies report more local recurrences after WLE, these often occur after the operation. However, it should be noted that this technique is primarily intended for less aggressive tumors without metastatic disease. Furthermore, anatomopathological control may be incomplete, as pointed out by Kimyai-Asaidi et al. [45]. This also explains why sentinel lymph nodes are rarely used in these cases. Conversely, amputations are reserved for more advanced forms, with a higher metastatic potential.
There is no clear consensus on whether to perform immediate versus delayed reconstruction. Our literature review revealed a notable rate of local recurrence, with 67 out of 373 patients (approximately 18%) experiencing recurrence, most often requiring secondary amputation. When reported, the time to recurrence ranged from 5 months to 11 years. Unfortunately, the recurrence details were not consistently reported by the authors. The timing of recurrence was mentioned in only two studies: at 24 and 32 months in Goettmann et al. [20] and at 36 months in Rayatt et al. [28]. Due to the heterogeneity in follow-up protocols and limited data, it was difficult to establish a clear correlation between surgical margin size and recurrence rate. However, the most extensive patient series, comprising 140 cases and reporting a recurrence rate of 16.4%, used low margins of 3 to 4 mm, including periosteum [20]. Reported cases of amputation following histological analysis of the resection specimen—including two in the literature—further support the rationale for delayed reconstruction, particularly in cases of invasive melanoma.
Two techniques have been proposed for margin assessment: intraoperative frozen section analysis, which is limited by the absence of specific immunostains (such as MART-1 and HMB-45), and the Mohs micrographic surgery technique, which can be performed either conventionally or in a staged manner. While Mohs is not recommended as a standard treatment for melanoma, it is employed in certain specific cases, particularly for lentigo maligna (Dubreuilh’s melanoma) [6,45,46,47]. It allows more precise histological control, but its accessibility remains limited, and its efficacy in this context is still debated. Most articles support this strategy, with a recurrence rate comparable to that of amputation [16,19,28,42,43]. Although some studies report a higher rate of local recurrence after wide local excision (WLE), it is important to note that this technique is generally reserved for less aggressive tumors without metastatic spread, which may influence recurrence patterns observed postoperatively.
Furthermore, anatomopathological control may be incomplete, as noted by Kimyai-Asaidi et al. [45]. This also explains why sentinel lymph nodes are rarely used in these cases. Conversely, amputations are reserved for more advanced forms, with a higher metastatic potential.
Reconstruction approaches vary from total skin grafts, dermal matrices, to pedicled or free flaps [17,22,26]. The choice depends on the location, the functional importance of the finger or toe, the need for mechanical strength, or, on the contrary, aesthetic requirements. Free flaps or flaps with a temporary pedicle (flag flap type) may be too invasive for certain indications [26]. In contrast, a graft combined with a dermal matrix is often a good compromise, especially for distal injuries with poor function [28]. The inner arm is frequently used as a donor site, due to its hairless and discreet appearance [48]. Dermal matrices provide post-operative comfort (reduced hypersensitivity) and allow coverage of exposed bone, enabling WLE with sub-periosteal resection or removal of the dorsal cortex of the last phalanx; however, they require additional operating time [28,33,36]. For toe lesions, healing by secondary intention can also be considered, as it is often well tolerated when wearing protective footwear. These approaches remain eligible for outpatient surgery under locoregional anesthesia.
In our review, most of the reconstruction techniques [13,14,15,16,17,18,19,21,23,24,27,30,31,32] described were based on skin grafting, alone or in association with a matrix or local flap, which could be explained by the low logistical and organizational constraints of this procedure, the quality of the results it provides, its simplicity of execution and its independence in relation to the size of the recipient site. Although a single surgical procedure is the most ergonomic option, our review found a similar number of one-stage and two-stage procedures. The latter, sometimes due to the time required to incorporate the matrix, could be dispensed with by the advent of single-layer matrices. As for the functional and cosmetic results mentioned in our review, they were often judged as “good”, “acceptable”, or “satisfactory”, which unfortunately made interpretation difficult and subjective. Objective results, at best reported by the patient using validated scores, would enable an effective comparison of the different techniques for a given patient profile.
In our experience, reconstruction should be adapted as far as possible to the patient’s profile [49,50]. However, for upper limb localization, the combination of a dermal matrix and a total skin graft appears to us to be the most suitable technique, due to the high quality of the functional and cosmetic results. For lower limb injuries, the use of pedicled flaps, such as the intermetatarsal flap [51], is our first-line option for reconstruction.
Neoadjuvant immunotherapy, already used for resectable stage III melanoma, could represent a turning point for localized forms such as SUM [52,53]. In the long term, it could make it possible to avoid certain amputations in favor of more conservative surgery such as WLE. However, these therapeutic options have not been widely studied, reflecting the persistent compartmentalization between medical and surgical disciplines.
The main limitations of our review relate to the lack of standardized functional evaluation of reconstructions, the heterogeneity of surgical techniques, and the absence of precise data on histological stage and recurrence. Overall study quality, as assessed using the Newcastle–Ottawa Scale and Joanna Briggs Institute checklists, was moderate: inclusion criteria and surgical protocols were generally well described, but sample sizes were small, techniques varied widely, and comparative analyses were scarce. Functional and aesthetic outcomes were assessed in a largely non-standardized manner, most often based on qualitative appraisal (surgeon judgment, patient-reported satisfaction or pain, or return to usual activities). Only Lee et al. [24] employed validated PROMs (QuickDASH and Foot Function Index), reporting superior functional scores compared with amputation. This heterogeneity and lack of standardized tools limit comparability across studies and may overestimate the functional and aesthetic benefits of conservative approaches. Nevertheless, most series reported preserved function and satisfactory cosmetic outcomes after functional surgery. Future prospective multicenter studies should systematically use validated PROMs (QuickDASH, Foot Function Index, POSAS, SCAR-Q) and standardized definitions for local and distant recurrence to more accurately assess the oncological safety and long-term quality-of-life impact of reconstructive techniques, particularly in thin invasive lesions.

5. Conclusions

The management of subungual melanoma is increasingly shifting towards WLE rather than amputation, particularly for in situ lesions or those with a low Breslow index. Across the included series, the recurrence rate is approximately 18%, with recurrence occurring between 5 months and 11 years, highlighting the need for long-term, systematic follow-up. Reconstructive techniques such as total skin grafts or dermal matrices can achieve satisfactory functional and aesthetic outcomes, yet objective, standardized evaluations are scarce, and adjuvant therapies are rarely reported. Future prospective, multicenter studies with standardized oncologic, functional, and quality-of-life endpoints are essential to optimize treatment strategies and ensure durable, patient-centered outcomes.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/jcm14175932/s1, Table S1: Quality assessment of included studies according to the Newcastle–Ottawa Scale (NOS) or the Joanna Briggs Institute (JBI) checklist, depending on study design. “Instrumented validates” refers to the use of standardized, psychometrically validated tools.

Author Contributions

Conceptualization, O.C. and E.L.; methodology, E.L. and O.C.; software, L.C.; validation, O.C., F.B. and E.L.; formal analysis, E.L. and L.C.; investigation, L.C.; resources, E.L., T.B., F.B. and H.M.; data curation, L.C.; writing—original draft preparation, L.C.; writing—review and editing, E.L., O.C., T.B. and H.M. visualization, O.C., E.L. and F.B.; supervision, O.C., E.L. and T.B.; project administration, O.C., E.L., T.B. and H.M.; funding acquisition, E.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board (or Ethics Committee) of University Institute for Locomotion and Sports (protocol code IRB00014528_2025_14 on 10 March 2025).

Informed Consent Statement

Not applicable.

Data Availability Statement

The corresponding authors can provide the data upon request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
SUMSubungual melanoma
WLEWide local excision (of nail apparatus)
FFinger
TToe
FTSGFull-thickness skin graft
STSGSplit-thickness skin graft
NANon available
Quick DASHScore Quick Disabilities of the arm, shoulder, and hand (score ranges from 0, no obstacles, to 100, maximum obstacles)
MMWSscore ranging from 0, maximum disability, to 100, no disability
Score AOFASThe American Orthopedic Foot and Ankle Score (score ranging from 0, maximum disability, to 90, no disability)
FSFunctional surgery
NOSNewcastle–Ottawa Scale
JBIJoanna Briggs Institute checklist
FFIFoot Function Index
PROMsPatient-reported outcome measures
SCCSquamous cell carcinoma

References

  1. Sun, Y.; Shen, Y.; Liu, Q.; Zhang, H.; Jia, L.; Chai, Y.; Jiang, H.; Wu, M.; Li, Y. Global trends in melanoma burden: A comprehensive analysis from the Global Burden of Disease Study, 1990–2021. J. Am. Acad. Dermatol. 2025, 92, 100–107. [Google Scholar] [CrossRef]
  2. Breslow, A. Tumor thickness in evaluating prognosis of cutaneous melanoma. Ann. Surg. 1978, 187, 440. [Google Scholar] [CrossRef]
  3. Breslow, A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann. Surg. 1970, 172, 902–908. [Google Scholar] [CrossRef]
  4. Lee, M.; Yoon, J.; Chung, Y.J.; Lee, S.Y.; Choi, J.Y.; Shin, O.R.; Park, H.Y.; Bahk, W.J.; Yu, D.S.; Lee, Y.B. Whole-exome sequencing reveals differences between nail apparatus melanoma and acral melanoma. J. Am. Acad. Dermatol. 2018, 79, 559–561.e1. [Google Scholar] [CrossRef]
  5. Feibleman, C.E.; Stoll, H.; Maize, J.C. Melanomas of the palm, sole, and nailbed: A clinicopathologic study. Cancer 1980, 46, 2492–2504. [Google Scholar] [CrossRef]
  6. Brodland, D.G. The treatment of nail apparatus melanoma with Mohs micrographic surgery. Dermatol. Surg. 2001, 27, 269–273. [Google Scholar]
  7. Haneke, E. Ungual melanoma—controversies in diagnosis and treatment. Dermatol. Ther. 2012, 25, 510–524. [Google Scholar] [CrossRef]
  8. Nakamura, Y.; Ohara, K.; Kishi, A.; Teramoto, Y.; Sato, S.; Fujisawa, Y.; Fujimoto, M.; Otsuka, F.; Hayashi, N.; Yamazaki, N.; et al. Effects of non-amputative wide local excision on the local control and prognosis of in situ and invasive subungual melanoma. J. Dermatol. 2015, 42, 861–866. [Google Scholar] [CrossRef]
  9. Cochran, A.M.; Buchanan, P.J.; Bueno, R.A.; Jr Neumeister, M.W. Subungual melanoma: A review of current treatment. Plast. Reconstr. Surg. 2014, 134, 259–273. [Google Scholar] [CrossRef]
  10. Temple-Oberle, C.; Nicholas, C.; Rojas-Garcia, P. Current Controversies in Melanoma Treatment. Plast. Reconstr. Surg. 2023, 151, 495e–505e. [Google Scholar] [CrossRef]
  11. Baran, R.G.-B.S.M.I.; Robert, C. Traitement du mélanome de l’appareil unguéal. Ann. Dermatol. Vénéréologie 2021, 1, 128–132. [Google Scholar] [CrossRef]
  12. Hovgaard, C.; Angermann, P.; Hovgaard, D. The social and economic consequences of finger amputations. Acta. Orthop. Scand. 1994, 65, 347–348. [Google Scholar] [CrossRef]
  13. Poumellec, M.A.; Camuzard, O.; Dumontier, C. Hook nail deformity. Hand. Surg. Rehabil. 2024, 43s, 101649. [Google Scholar] [CrossRef]
  14. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 372, n71. [Google Scholar] [CrossRef]
  15. Anda-Juárez, M.C.; Martínez-Velasco, M.A.; Fonte-Ávalos, V.; Toussaint-Caire, S.; Domínguez-Cherit, J. Conservative surgical management of in situ subungual melanoma: Long-term follow-up. An. Bras. Dermatol. 2016, 91, 846–848. [Google Scholar] [CrossRef]
  16. Lazar, A.; Abimelec, P.; Dumontier, C. Full thickness skin graft for nail unit reconstruction. J. Hand. Surg. Br. 2005, 30, 194–198. [Google Scholar] [CrossRef]
  17. Puhaindran, M.E.; Cordeiro, P.G.; Disa, J.J.; Mehrara, B.J.; Athanasian, E.A. Full-thickness skin graft after nail complex resection for malignant tumors. Tech. Hand. Up. Extrem. Surg. 2011, 15, 84–86. [Google Scholar] [CrossRef]
  18. Flores-Terry, M.; Romero-Aguilera, G.; Mendoza, C.; Franco, M.; Cortina, P.; Garcia-Arpa, M.; Gonzalez-Ruiz, L.; Garrido, J.A. Functional Surgery for Malignant Subungual Tumors: A Case Series and Literature Review. Actas Dermosifiliogr. (Engl. Ed.) 2018, 109, 712–721. [Google Scholar] [CrossRef]
  19. Moehrle, M.; Metzger, S.; Schippert, W.; Garbe, C.; Rassner, G.; Breuninger, H. “Functional” surgery in subungual melanoma. Dermatol. Surg. 2003, 29, 366–374. [Google Scholar]
  20. Goettmann, S.; Moulonguet, I.; Zaraa, I. In situ nail unit melanoma: Epidemiological and clinic-pathologic features with conservative treatment and long-term follow-up. J. Eur. Acad. Dermatol. Venereol. 2018, 32, 2300–2306. [Google Scholar] [CrossRef]
  21. Sinno, S.; Wilson, S.; Billig, J.; Shapiro, R.; Choi, M. Primary melanoma of the hand: An algorithmic approach to surgical management. J. Plast. Surg. Hand. Surg. 2015, 49, 339–345. [Google Scholar] [CrossRef]
  22. Oh, B.H.; Lee, S.; Park, J.W.; Lee, J.Y.; Roh, M.R.; Nam, K.A.; Chung, K.Y. Risk of recurrence of nail unit melanoma after functional surgery versus amputation. J. Am. Acad. Dermatol. 2023, 88, 1017–1023. [Google Scholar] [CrossRef]
  23. Wollina, U.; Tempel, S.; Hansel, G. Subungual melanoma: A single center series from Dresden. Dermatol. Ther. 2019, 32, e13032. [Google Scholar] [CrossRef]
  24. Lee, K.T.; Park, B.Y.; Kim, E.J.; Kim, J.H.; Jang, K.T.; Choi, S.H.; Lee, D.Y.; Mun, G.H. Superthin SCIP Flap for Reconstruction of Subungual Melanoma: Aesthetic Functional Surgery. Plast. Reconstr. Surg. 2017, 140, 1278–1289. [Google Scholar] [CrossRef]
  25. Sureda, N.; Phan, A.; Poulalhon, N.; Balme, B.; Dalle, S.; Thomas, L. Conservative surgical management of subungual (matrix derived) melanoma: Report of seven cases and literature review. Br. J. Dermatol. 2011, 165, 852–858. [Google Scholar] [CrossRef]
  26. Neczyporenko, F.; André, J.; Torosian, K.; Theunis, A.; Richert, B. Management of in situ melanoma of the nail apparatus with functional surgery: Report of 11 cases and review of the literature. J. Eur. Acad. Dermatol. Venereol. 2014, 28, 550–557. [Google Scholar] [CrossRef]
  27. Terushkin, V.; Brodland, D.G.; Sharon, D.J.; Zitelli, J.A. Digit-Sparing Mohs Surgery for Melanoma. Dermatol. Surg. 2016, 42, 83–93. [Google Scholar] [CrossRef]
  28. Rayatt, S.S.; Dancey, A.L.; Davison, P.M. Thumb subungual melanoma: Is amputation necessary? J. Plast. Reconstr. Aesthet. Surg. 2007, 60, 635–638. [Google Scholar] [CrossRef]
  29. Imakado, S.; Sato, H.; Hamada, K. Two cases of subungual melanoma in situ. J. Dermatol. 2008, 35, 754–758. [Google Scholar] [CrossRef]
  30. Liu, T.H.; Hsieh, M.C.; Chou, P.R.; Huang, S.H. Reconstruction for Defects of Total Nail Bed and Germinal Matrix Loss with Acellular Dermal Matrix Coverage and Subsequently Skin Graft. Medicina 2020, 56, 17. [Google Scholar] [CrossRef]
  31. Crisan, D.; Gülke, J.; Janetzko, C.; Kastler, S.; Treiber, N.; Scharffetter-Kochanek, K.; Schneider, L.A. Digit preserving surgery of subungual melanoma: A case series using vacuum assisted closure and full-thickness skin grafting. J. Eur. Acad. Dermatol. Venereol. 2017, 31, e537–e538. [Google Scholar] [CrossRef]
  32. High, W.A.; Quirey, R.A.; Guillén, D.R.; Munõz, G.; Taylor, R.S. Presentation, histopathologic findings, and clinical outcomes in 7 cases of melanoma in situ of the nail unit. Arch. Dermatol. 2004, 140, 1102–1106. [Google Scholar] [CrossRef]
  33. Chow, W.T.; Bhat, W.; Magdub, S.; Orlando, A. In situ subungual melanoma: Digit salvaging clearance. J. Plast. Reconstr. Aesthet. Surg. 2013, 66, 274–276. [Google Scholar] [CrossRef]
  34. Duarte, A.F.; Correia, O.; Barros, A.M.; Azevedo, R.; Haneke, E. Nail matrix melanoma in situ: Conservative surgical management. Dermatology 2010, 220, 173–175. [Google Scholar] [CrossRef]
  35. Smock, E.D.; Barabas, A.G.; Geh, J.L. Reconstruction of a thumb defect with Integra following wide local excision of a subungual melanoma. J. Plast. Reconstr. Aesthet. Surg. 2010, 63, e36–e37. [Google Scholar] [CrossRef]
  36. Bjedov, S.; Ježić, I.; Bulić, K. Reconstruction of a Thumb Defect Following Subungual Melanoma Resection Using Foucher’s Flap. Acta. Dermatovenerol. Croat. 2019, 27, 51–52. [Google Scholar]
  37. Motta, A.; López, C.; Acosta, A.; Peñaranda, C. Subungual melanoma in situ in a Hispanic girl treated with functional resection and reconstruction with onychocutaneous toe free flap. Arch. Dermatol. 2007, 143, 1600–1602. [Google Scholar] [CrossRef]
  38. Hayashi, K.; Uhara, H.; Koga, H.; Okuyama, R.; Saida, T. Surgical treatment of nail apparatus melanoma in situ: The use of artificial dermis in reconstruction. Dermatol. Surg. 2012, 38, 692–694. [Google Scholar] [CrossRef]
  39. Boyer, A. A fungus hematode du petit doigt. Gaz. Med. 1834, 212. [Google Scholar]
  40. Levit, E.K.; Kagen, M.H.; Scher, R.K.; Grossman, M.; Altman, E. The ABC rule for clinical detection of subungual melanoma. J. Am. Acad. Dermatol. 2000, 42 Pt 1, 269–274. [Google Scholar] [CrossRef]
  41. Tran, K.T.; Wright, N.A.; Cockerell, C.J. Biopsy of the pigmented lesion—When and how. J. Am. Acad. Dermatol. 2008, 59, 852–871. [Google Scholar] [CrossRef]
  42. Guillot, B.; Dalac, S.; Denis, M.G.; Dupuy, A.; Emile, J.F.; De La Fouchardiere, A.; Hindie, E.; Jouary, T.; Lassau, N.; Mirabel, X. French updated recommendations in Stage I to III melanoma treatment and management. J. Eur. Acad. Dermatol. Venereol. 2017, 31, 594–602. [Google Scholar] [CrossRef]
  43. Park, K.G.; Blessing, K.; Kernohan, N.M. Surgical aspects of subungual malignant melanomas. The Scottish Melanoma Group. Ann. Surg. 1992, 216, 692–695. [Google Scholar] [CrossRef]
  44. Jo, G.; Cho, S.I.; Choi, S.; Mun, J.H. Functional surgery versus amputation for in situ or minimally invasive nail melanoma: A meta-analysis. J. Am. Acad. Dermatol. 2019, 81, 917–922. [Google Scholar] [CrossRef]
  45. Kimyai-Asadi, A.; Katz, T.; Goldberg, L.H.; Ayala, G.B.; Wang, S.Q.; Vujevich, J.J.; Jih, M.H. Margin involvement after the excision of melanoma in situ: The need for complete en face examination of the surgical margins. Dermatol. Surg. 2007, 33, 1434–1439; discussion 9–41. [Google Scholar] [CrossRef]
  46. Hewitt, B.B.; Bradley, E.; Berger, A.C. Margins of Melanoma Excision and Modifications to Standards. Surg. Oncol. Clin. N. Am. 2020, 29, 339–347. [Google Scholar] [CrossRef]
  47. Swetter, S.M.; Tsao, H.; Bichakjian, C.K.; Curiel-Lewandrowski, C.; Elder, D.E.; Gershenwald, J.E.; Guild, V.; Grant-Kels, J.M.; Halpern, A.C.; Johnson, T.M.; et al. Guidelines of care for the management of primary cutaneous melanoma. J. Am. Acad. Dermatol. 2019, 80, 208–250. [Google Scholar] [CrossRef]
  48. Majchrzak, A.; Paleu, G.; Guena, B.; Chaput, B.; Camuzard, O.; Lupon, E. Posterior arm perforator flap for coverage of the scapular area. Ann. Chir. Plast. Esthet. 2025, 70, 63–66. [Google Scholar] [CrossRef]
  49. Meresse, T.; Lupon, E.; Berkane, Y.; Classe, J.M.; Camuzard, O.; Gangloff, D. Oncologic plastic surgery: An essential activity to develop in France. Ann. Chir. Plast. Esthet. 2023, 68, 286–287. [Google Scholar] [CrossRef]
  50. Albadia, R.; Rousset, P.; Massalou, D.; Camuzard, O.; Montaudié, H.; Lupon, E. Management of a large abdominal dermatofibrosarcoma protuberans requiring a life-threatening excision: A case report. Int. J. Surg. Case. Rep. 2025, 133, 111579. [Google Scholar] [CrossRef]
  51. Saboye, M.; Majchrzak, A.; d’Andréa, G.; Bronsard, N.; Camuzard, O.; Lupon, E. The First Dorsal Metatarsal Artery Perforator Flap: A Description and Anatomical Study. J. Clin. Med. 2025, 14, 4136. [Google Scholar] [CrossRef] [PubMed]
  52. Blank, C.U.; Lucas, M.W.; Scolyer, R.A.; van de Wiel, B.A.; Menzies, A.M.; Lopez-Yurda, M.; Hoeijmakers, L.L.; Saw, R.P.; Lijnsvelt, J.M.; Maher, N.G.; et al. Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma. N. Engl. J. Med. 2024, 391, 1696–1708. [Google Scholar] [CrossRef] [PubMed]
  53. Chouquet, L.; Poissonnet, G.; Picard, A.; Camuzard, O.; Gangloff, D.; Lupon, E. What’s new in oncologic plastic surgery in 2025? Ann. Chir. Plast. Esthet. 2025, 5, S0294–S1260. [Google Scholar] [CrossRef]
Figure 1. Flowchart.
Figure 1. Flowchart.
Jcm 14 05932 g001
Table 1. Characteristics of included studies on reconstruction after wide local excision for subungual melanoma.
Table 1. Characteristics of included studies on reconstruction after wide local excision for subungual melanoma.
Ref.Type of Article

Number of
Patients
Distribution

Mean Age (Years) (Range)
Localization

F (Finger)
T (Toe)
(n)
Local
Extension
Presence of
Previous Biopsy

Margins from Nail Apparatus
Strategy of
Reconstruction
Surgical Management
Side Effects,
Complications
Complementary
Treatment
ResultsFollow Up
Mean (Range)
Anda-Juarez et al., An Bras Dermatol, 2016 [15]Retrospective

15 patients (9F, 6M)

31 (4–66)
Right hand: F2 (2), F4 (2), F5 (1)
Left hand:
F1 (1), F5 (3)
Right foot (5):
T1 (5)
Left foot (1):
T1
SUM in situ5 mm

Supra periosteum resection
FTSG (14)

Banner flap (1 patient)
No recurrence

Inclusion cysts (4)
Spicules (6)
Hypersensitivity (4)
Moderate chronic pain (1)
Hyperpigmentation of the skin graft (9)
NAFunctional and cosmetic outcomes were good in all of them 55 months (12–98)
Lazar et al., HandSurg Br, 2005 [16]Retrospective

13 patients (8F, 5M)

10 patients with SUM (7F, 3M)

40 (NA)
Right hand
F1 (3), F3 (1), F5 (1)

Left hand:
F1 (2), F5(3)
SUM in situ5 mmImmediate FTSG harvested from same forearm (9)
Delayed FTSG harvested from same forearm (1)
Temporary finger exclusion (1 case)
Epidermal cyst (5 cases)
NASensitivity: Weber 4–6 mm (7), NA (1)
Normal function (4), Slightly limited function (5), NA (1)
Cosmetic outcome: Satisfied or normal (9), NA (1)
48 months (6–84)
Puhaindran et al., Tech Hand Up Extrem Surg, 2011 [17]Retrospective

10 patients
(4F, 6 M)

6 patients with a SUM

MA 52 (24–80)
NASUM in situ, <2 cm diameter2 mm to nail foldImmediate FTSGPositive margin (1), treated by PID Disarticulation

Secondary surgery:
Epidermal inclusion cyst (1)
Nail remnant (1)
NAAcceptable appearance for all patients (assessed by 2 surgeons)

Patients satisfied (6)

Unrestricted use of the hand (6)
35 months (8–72)
Flores-Terry et al., Actas Dermosifiliogr, 2018 [18]Retrospective

11 patients

7 patients with SUM (4F, 3M)

5 patients (3F, 2M)
treated by WLE

61 (45–81)
Right hand:
F2 (1)
F3 (1)

Left hand
F1 (1)
F2 (1)

Right foot:
T1 (1)
SUM in situ (4)

or Sum with Breslow < 1 mm (1)
Previous biopsy
5 mm
Supra periosteum resection
Circumferential advancement flap
and
Immediate FTSG
No recurrency (5)

Wound infection (2)
subungual spicules (1), moderate stiffness of DIP of one finger (1), hypersensitivity to cold (2), hypersensitivity to mild trauma (4)
NAPatients were satisfied with the procedure and the results obtained (5)

Satisfaction was good, and the impact on quality of life was minimal (5)
39 months (12–96)
Moehrle et al., Dermatol Surg, 2003 [19]Retrospective

62 patients with SUM (25H, 37F)

31 treated by WLE (11H, 20F)

MA 61
F1,2,3,4,5 (20)
T1,2,3,4,5 (11)
SUM in situ


Invasive SUM
Breslow < 1 mm
(6)
Breslow 1 to 2 mm
(8)
Breslow 2 to 4 mm
(6)
Breslow > 4 mm
(4)
NA: (7)
5 mm
WLE with safety margin without bone resection (3)
WLE with safety margin with resection of the distal part of the distal phalanx (28)
FTSG with pulpal advancement flap
Single stage (1)
Several stages (30)
Unspecified reconstruction after definitive three-dimensional histology
Recurrences (20 patients)
Local recurrence (2)
In transit recurrence (1)
Lymph node metastasis (7)
Distant metastasis (1)
NAFunction and cosmesis of the involved finger or toe “preserved”54 months (NA)
Goettmann et al., J Eur Acad Dermatol Venereol, 2018 [20]Retrospective

63 patients (44F, 19M)

58 treated by WLE

51 (NA)
F1 (24)
F2,3,4,5 (23)
T1 (10)
T3 (1)
All SUM, if pulp is not involvedNo previous biopsy
WLE (12)
Partial excision of the appliance, removal of the lesion, and the nearby paronychium (47)
Healing by secondary intention (52)

FTSG (3 patients)

Flap (1)
Local recurrences at 24 and 32 months treated by amputation (2)
Spicules (7)
Epidermal cysts (2)
NANo functional discomfort (20)
Moderate discomfort (14) Aesthetic discomfort was judged to be absent (29) Moderate aesthetic discomfort (8) Severe aesthetic discomfort (2)
120 months (NA)
Chow et al., J Plast Reconstru Surg, 2013 [33]Case report

1M with SUM in situ

41
Right T1 (1)SUM in situBiopsy
10 mm
WLE with a layer of bone
Immediate FTSG
(harvested from the groin)
NANAAcceptable cosmetic result (assessed by surgeon)5 months
Duarte et al., Dermatol, 2010 [34]Case report

1F with SUM in situ

61
Right F1 (1)SUM in situ Excisional biopsy
3 weeks later
3 mm margin WLE
FTSG taken from the armNo local recurrence or metastasisNAThumb function completely preserved12 months
High et al., Arch Dermatol, 2004 [32]Retrospective

7 patients (5F, 2M) with SUM in situ

4 patients treated by WLE

MA 56 (NA)
Right hand (1): F2
Left hand (2): F2 (1), F5 (1)
Right foot (1): T1 (1)
SUM in situ Previous biopsy
MOHS surgery: 1 stage (3)
2 stages (1)
FTSG taken from the arm (3)

cross finger flap (1)
Recurrence: (1) treated by revisional amputation NANA24 months (10–29)
Sinno et al., J Plast Surg Hand Surg, 2015 [21]Retrospective

35 patients with melanoma of the hand (24F, 11M)

18 patients with SUM

10 patients with SUM treated by WLE
F1 (8)
F2 (12)
F3 (3)
F5 (3)
Melanomas in situ (7)
Invasive Melanoma T2 (1 patients)
B = 2.5 mm
Invasive Melanoma T3 (2); B = 3.00 mm and B = 3.08 mm
5 mm FTSG (3)
Paronychial advancement flap + FTSG (3)
Paronychial advancement flap + forearm flap + FTSG (1)
Paronychial advancement flap + FTSG Volar Flap FTSG (1)
FTSG Volar and dorsal advancement flaps (1)
FTSG Local advancement flap (1)
Revisional amputation (3)
Unknown (1)
Deceased (1)
NANA47 months (7–74)
Smock et al., J Plast Reconstr Aesthet Surg, 2010 [35]Case report
1M

44
Right F1 (1)Ulcerated SUM Breslow of 1.2 mmPrevious Biopsy
10 mm, including the periosteum
Immediate reconstruction by dermal matrix (INTEGRA)
STSG 3 weeks later
NoneNAFully functional thumb and a good cosmetic result
Went back to job at 4 weeks
24 months
Bjedov et al., Acta Dermato Venereol Croat, 2019 [36]Case report (1)
F, 31
Left F1 (1)SUM in situSeveral nail matrix biopsies

5 mm, with periosteum

Mohs analysis
Pedicled innervated Fascio-cutaneous Foucher’s flap
The donor site was covered with an FTSG taken from the volar side of the elbow.
NoneNAThe hand was fully functional, and the patient was very satisfied with the appearance of the thumb
Full sensory cortical reorientation
3 months
Oh et al., J Am Acad Dermatol, 2023 [22]Retrospective

140 patients with SUM
107 with conservative treatment
(57F, 50H)
Mean age: 56
F1,2,3,4,5 (71)
T1,2,3,4,5 (36)
If no bone invasion (MRI + biopsy)Biopsy and MRI
at least 3 to 4 mm, with periosteum
NARecurrence (23 patients):
Local recurrence (15)
Distant recurrences (8)
NANA45 months (14–76)
Motta et al., Arch Dermatol, 2007 [37]Case report

12 years old, F
Right F1 (1)SUM in situBiopsy
WLE with Mohs Micrographic analysis
5–10 mm (lateral)
5 mm (proximal and distal edges)
Two stages

Second stage (1 week later)
microvascular composite onychocutaneous free flap from the right first toe
NANANormal nail growth and full mobility of the interphalangeal thumb joint were present3 months
Wollina et al., Dermatol Ther, 2019 [23]Retrospective
Series of 12 patients with SUM)

6 patients with conservative treatment (2F, 4M)

76 (NA)
Right foot T1 (2)
T3 (1)
Left foot:
T1 (3)
SUM with Breslow between 1.6 mm and 4.8 mm Wide excision (4)
Excision with delayed Mohs surgery (2)
Full-thickness skin transplantation.

One patient refused, second intention healing
Local relapse (2)
Later metastasis (1)
Satellites only (1 patient, B = 2.55)
Liver, pancreas, spleen, lymph nodes, stomach, adrenal glands, greater omentum, CNS (1, with Breslow = 4.8 mm)
In transit, lymph node regional, pericardium (1, with Breslow = 3.20)
Sentinel Lymph node (4), with micro-invasion (1)
Polychemotherapy for later metastasis (1)
Transit metastases treated by erbium YAG-laser as a palliative measure (1)
interferon-alfa therapy for 9 years after surgery, satellite metastasis (1)
Adjuvant radiotherapy (1)
NA104 months (17–208)
Crisan et al., Acad Dermatol Venereol, 2017 [31]Retrospective

Series of 7 patients (3F, 4H)

64 (NA)
F1 (3)
F4 (3)
T1 (1)
SUM in situ

pT1a (1)
pT1b (1)
WLE (7)
NA
First stage: vacuum-assisted closure

Second stage: FTSG (5)
Second stage amputation (2 patients) for:
-DIP joint arthritis (1)
-Positive margin (1)
NAAt 6 weeks, the 5 patients grafted could resume normal activity
Good cosmetic and functional
12 months (NA)
Lee et al., Plast Reconstr Surg, 2017 [24]Prospective

41 patients with conservative treatment (21M, 20F)

51.1 (NA)
Fingers: 25
Toes: 16
SUM with Breslow thickness of ≤2 mm on preoperative biopsyPreoperative biopsy
5 mm with periosteum excised
(10 mm margin if invasive lesion)
Immediate reconstruction by SCIP flap with a final thickness ranging from 1.5 to 4 mm after defatting

(Scouted with Doppler)


End-to-end anastomosis with digital artery and dorsal vein

Donor site primary closing
Necrosis of the flap (1) (arterial insufficiency) Venous congestion (3) with partial necrosis of the flap
Seroma of the donor site (1).
Recurrences:
-local recurrence (1)
-metastasis in transit (1) Second surgical stage until degreasing (12)
NAAverage healing time: 15 days
Questionnaire carried out on 26 patients: WLE in the upper limb (14):
The mean Quick-DASH score was 1.3 (range 0 to 6.8).
WLE in the lower limb (12): FFI survey for foot lesions.
mean score was 3.1 (range 0 to 8.0)
31 months (NA)
Hayashi et al., Dermatol Surg, 2012 [38]Case report
(1M), 52
Left F3SUM in situNo biopsy
5 mm with excision of periosteum
Immediate reconstruction with artificial dermis (PELNAC)

Second stage at 4 weeks with FTSG
No recurrency
No metastasis
NAGood cosmetic results 3 months
Sureda et al., Br J Dermatol, 2011 [25]Retrospective

Series of 7 patients (5F, 2M)

MA 58 y
F1 (2), F2 (2), F4 (1)
T1 (2)
SUM in situ (5)
or
minimally invasive SUM (2)

(Breslow 0.2 and 0.15)
Biopsy systematically
5–10 mm
Deep margin was bone contact
Immediate FTSG taken from the internal aspect of an armNo recurrenceNAInterrogation of patient and observer:
High level of satisfaction, a good functional and quite good cosmetic result.
45 months (24–84)
Neczyporenko et al., J Eur Acad Dermatol Venereol, 2014 [26]Retrospective

Series of 11 patients (8F, 3M)

48 (NA)
Right hand: F1 (3), F2 (1), F5 (1)
Left hand: F1 (1) F2 (1)
T1 (3), T2 (1)
Melanoma in situBiopsy systematically (tangential or punch)
6 mm
Immediate FTSG (6)

Secondary intention and delayed FTSG (5)
Tendon sheath hematoma (1)
Lymphangitis post (1)
Recurrence treated by secondary amputation and sentinel node (2) (7- and 11 years post op)
NAHealing by secondary intention and grafting were fully satisfactory, cosmetically and functionally65 months (5–167)
Terushkin et al., Dermatol Surg, 2016 [27]Retrospective

Series of 40 patients (21F, 19M)

63 (NA)
NAWLE in cases of extensive SUM (>40%
of the bed)
Excisional biopsy with Mohs micrograph,
Supra Periosteum dissection
Second intention
FTSG
STSG
Recurrences (5) Second operation with complete excision of the matrix (2) Amputation (2) Death due to metastasis (1)NANA76 months (2–276)
Rayatt et al., Plast Reconstr Aesthet Surg, 2007 [28]Retrospective

Series of 4 patients

56 (NA)
F1 (4)SUM without deep margin clinically involved

Breslow 0.9 mm to 4 mm
All had initial biopsies to confirm the diagnosis
10 mm including the periosteum
Immediate:
-Foucher flap (1)
-Flag flap (2)

Delayed reconstruction (flag flap) (1)
Recurrence at 36 months treated by amputation (1)NAUsefully maintain function. 72 months (−117)
Imakado et al., J Dermatol, 2008 [29]Retrospective

Series of 2 patients (1M, 1F)

50
Left F3 (1)
Right F5 (1)
SUM in situAll the nail apparatus with nail foldsImmediate FTSGNo recurrenceNANA27 months (6–48)
Liu et al., Medicina, 2020 [30]Retrospective

Series of 4 patients with malignant tumor of nail apparatus

3 patients with SUM suspicion (1F, 2M)

MA 55 y
Left T1 (1)
Right T1 (2)
SUM in situ (2)

hyperpigmentation in basal layer of epidermis (1)
Previous biopsy (2)
WLE
Adequate margin control confirmed by intraoperative frozen sections
Two-stage reconstruction
Immediate acellular dermal matrix (PELNAC)

At 10 days, the acellular dermal matrix was removed and re-dressed with a new one at the outpatient clinic

FTSG at 3 weeks
No RecurrenceNAThese patients experienced minimal change in body contour, mild but acceptable functional deficit, and satisfying aesthetic results.9 months (5–13)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Chouquet, L.; Boukari, F.; Balaguer, T.; Montaudié, H.; Camuzard, O.; Lupon, E. Reconstruction After Wide Excision of the Nail Apparatus in the Treatment of Melanoma: A Systematic Literature Review. J. Clin. Med. 2025, 14, 5932. https://doi.org/10.3390/jcm14175932

AMA Style

Chouquet L, Boukari F, Balaguer T, Montaudié H, Camuzard O, Lupon E. Reconstruction After Wide Excision of the Nail Apparatus in the Treatment of Melanoma: A Systematic Literature Review. Journal of Clinical Medicine. 2025; 14(17):5932. https://doi.org/10.3390/jcm14175932

Chicago/Turabian Style

Chouquet, Luc, Feriel Boukari, Thierry Balaguer, Henri Montaudié, Olivier Camuzard, and Elise Lupon. 2025. "Reconstruction After Wide Excision of the Nail Apparatus in the Treatment of Melanoma: A Systematic Literature Review" Journal of Clinical Medicine 14, no. 17: 5932. https://doi.org/10.3390/jcm14175932

APA Style

Chouquet, L., Boukari, F., Balaguer, T., Montaudié, H., Camuzard, O., & Lupon, E. (2025). Reconstruction After Wide Excision of the Nail Apparatus in the Treatment of Melanoma: A Systematic Literature Review. Journal of Clinical Medicine, 14(17), 5932. https://doi.org/10.3390/jcm14175932

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop